CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 8-K Event Other events
- 3/A Insider 3/A
- 10-K Report Annual Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Shares withheld for taxes CEO & President gave up 42,192 shares (to pay taxes)
- S-3 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Option exercise Chief Financial Officer acquired 7,598 shares (option exercise)
- 4 Shares withheld for taxes CEO & President gave up 4,273 shares (to pay taxes)
- UPLOAD Other SEC-generated Letter
- 4 Conversion See remarks acquired 9,986,920 shares (conversion)
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure · Other events
- 424B5 Offering Prospectus
Page 11 of 28 · 557 filings